Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)

Ann Intern Med. 2020 Oct 20;173(8):670-672. doi: 10.7326/M20-1550. Epub 2020 May 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / metabolism
  • Cytochrome P-450 CYP3A Inhibitors / pharmacokinetics
  • Female
  • Humans
  • Inpatients*
  • Lopinavir / pharmacokinetics*
  • Male
  • Middle Aged
  • Pandemics*
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / metabolism
  • Ritonavir / pharmacokinetics*
  • SARS-CoV-2
  • Young Adult

Substances

  • Cytochrome P-450 CYP3A Inhibitors
  • Lopinavir
  • Ritonavir

Supplementary concepts

  • COVID-19 drug treatment